PP
IRMD icon

PDT Partners’s iRadimed IRMD Stock Holding History

PDT Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
+10,533
New +$1.05M 0.06% 341
2022
Q1 		– Sell
-4,631
Closed -$214K – 1014
2021
Q4 		$214K Buy
+4,631
New +$187K 0.02% 753
2020
Q2 		– Sell
-9,738
Closed -$208K – 739
2020
Q1 		$208K Buy
+9,738
New +$232K 0.02% 556

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's IRMD Position: Q1 2026 in Review

PDT Partners opened a new position in iRadimed (IRMD) in Q1 2026: 10,533 shares worth $1.01M. The stake represents 0.06% of the portfolio and ranks #341 among its holdings. This is a return to the name: PDT Partners previously reported a position in IRMD as recently as Q4 2021.

PDT Partners first reported a position in IRMD in Q1 2020 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • PDT Partners held 10,533 shares of iRadimed worth $1.01M as of Q1 2026.
  • iRadimed was a new PDT Partners position in Q1 2026.
  • iRadimed made up 0.06% of PDT Partners's portfolio in Q1 2026, its #341 holding.
  • PDT Partners first reported a position in iRadimed in Q1 2020 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.